E-LIB Suche - Ergebnisse für: Merali, Samira

1

Safety, tolerability, pharmacokinetics and pharmacodynamics..:

Perera, Vidya ; Abelian, Grigor ; Luettgen, Joseph...
Scientific Reports. 14 (2024) 1 - p. , 2024

2

PAR4 Antagonism in Patients With Coronary Artery Disease Re..:

Nash, Jennifer ; Meah, Mohammed N. ; Whittington, Beth...
Arteriosclerosis, Thrombosis, and Vascular Biology. 44 (2024) 4 - p. 987-996 , 2024

Link: https://doi.org/10.1161/..

3

Effect of Activated Charcoal on Mavacamten Pharmacokinetics..:

Merali, Samira ; Chiang, Manting ; Sychterz, Caroline...
American Journal of Cardiovascular Drugs. 24 (2024) 4 - p. 569-575 , 2024

Link: https://doi.org/10.1007/..

4

Recommendation of mavacamten posology by model‐based analys..:

Merali, Samira ; Salinger, David H. ; Palmisano, Maria...
CPT: Pharmacometrics & Systems Pharmacology. , 2024

Link: https://doi.org/10.1002/..

5

First-in-human study to assess the safety, pharmacokinetics..:

Merali, Samira ; Wang, Zhaoqing ; Frost, Charles...
Platelets. 34 (2023) 1 - p. , 2023

Link: https://doi.org/10.1080/..

6

Evaluation of safety, pharmacokinetics, and pharmacodynamic..:

Merali, Samira J. ; Byon, Wonkyung ; Patel, Yogesh T....
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 4 - p. 500-512 , 2023

Link: https://doi.org/10.1002/..

7

Physiologically Based Pharmacokinetic Modeling and Simulati..:

Chiang, Manting ; Sychterz, Caroline ; Perera, Vidya...
Clinical Pharmacology & Therapeutics. 114 (2023) 4 - p. 922-932 , 2023

Link: https://doi.org/10.1002/..

8

Drug–Drug Interaction Potential of Mavacamten with Oral Con..:

Chiang, Manting ; Sychterz, Caroline ; Gaohua, Lu...
The Journal of Clinical Pharmacology. 63 (2023) 11 - p. 1275-1282 , 2023

Link: https://doi.org/10.1002/..

9

Apixaban Use in Obese Patients: A Review of the Pharmacokin..:

Jamieson, Michael J. ; Byon, Wonkyung ; Dettloff, Richard W....
American Journal of Cardiovascular Drugs. 22 (2022) 6 - p. 615-631 , 2022

Link: https://doi.org/10.1007/..

10

Performance Verification of CYP2C19 Enzyme Abundance Polymo..:

Sychterz, Caroline ; Gardner, Iain ; Chiang, Manting...
Metabolites. 12 (2022) 10 - p. 1001 , 2022

Link: https://doi.org/10.3390/..

11

New oral protease-activated receptor 4 antagonist BMS-98612..:

Merali, Samira ; Wang, Zhaoqing ; Frost, Charles...
Platelets. 33 (2022) 7 - p. 969-978 , 2022

Link: https://doi.org/10.1080/..

12

Pharmacokinetics and safety of mavacamten in healthy Chines..:

Wu, Xiaojie ; Chen, Nanye ; Hsu, Peiwen...
Clinical and Translational Science. 17 (2024) 7 - p. , 2024

Link: https://doi.org/10.1111/..

13

Evaluation of safety, pharmacokinetics, and pharmacodynamic..:

Merali, Samira J ; Byon, Wonkyung ; Patel, Yogesh T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088081/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Apixaban Use in Obese Patients: A Review of the Pharmacokin..:

Jamieson, Michael J ; Byon, Wonkyung ; Dettloff, Richard W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618533/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Performance Verification of CYP2C19 Enzyme Abundance Polymo..:

Sychterz, Caroline ; Gardner, Iain ; Chiang, Manting...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607610/. , 2022

Link: http://www.ncbi.nlm.nih...